Insights

Expanding Diagnostic Portfolio Todos Medical's development of multiple proprietary blood tests for cancer, neurodegenerative disorders, and infectious diseases presents opportunities to cross-sell and expand offerings to healthcare providers and laboratories interested in comprehensive diagnostic solutions.

Recent Patent Approvals The company's recent Notices of Allowance from the USPTO for its TBIA platform and tollovid ingredients indicate strong intellectual property assets, providing a competitive advantage that can be leveraged in negotiations with hospitals and industry partners.

Strategic Acquisitions The acquisition of Provista Diagnostics enhances Todos' capabilities with CLIA/CAP certified labs and a commercially-stage breast cancer blood test, opening avenues for sales to clinical laboratories and specialized cancer centers seeking reliable diagnostic tests.

COVID-19 Testing Expansion Todos' ongoing collaborations and distribution agreements for COVID-19 PCR and antibody tests, along with clinical trials of Tollovir for COVID-19 hospital treatments, create opportunities to supply testing kits and therapeutics to health institutions managing pandemic response.

Focus on Innovative Technologies The company's patented TBIA technology and its unique approach to cancer and neurodegenerative disease detection position it favorably for partnerships with biotech firms, research centers, and hospitals aiming to incorporate cutting-edge diagnostics into their offerings.

Todos Medical Tech Stack

Todos Medical uses 8 technology products and services including WordPress, Open Graph, oEmbed, and more. Explore Todos Medical's tech stack below.

  • WordPress
    Content Management System
  • Open Graph
    Content Management System
  • oEmbed
    Dev Tools
  • Google Workspace
    Email
  • jQuery Migrate
    Javascript Libraries
  • PHP
    Programming Languages
  • Yoast SEO
    Search Engines
  • GoDaddy
    Web Hosting

Media & News

Todos Medical's Email Address Formats

Todos Medical uses at least 2 format(s):
Todos Medical Email FormatsExamplePercentage
First.L@todosmedical.comJohn.D@todosmedical.com
67%
First@todosmedical.comJohn@todosmedical.com
16%
Last@todosmedical.comDoe@todosmedical.com
9%
First.Last@todosmedical.comJohn.Doe@todosmedical.com
8%

Frequently Asked Questions

Where is Todos Medical's headquarters located?

Minus sign iconPlus sign icon
Todos Medical's main headquarters is located at 40 Wall Street, Suite 2702. The company has employees across 2 continents, including North AmericaAsia.

What is Todos Medical's phone number?

Minus sign iconPlus sign icon
You can contact Todos Medical's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Todos Medical's official website and social media links?

Minus sign iconPlus sign icon
Todos Medical's official website is tollohealth.com and has social profiles on LinkedInCrunchbase.

What is Todos Medical's SIC code NAICS code?

Minus sign iconPlus sign icon
Todos Medical's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Todos Medical have currently?

Minus sign iconPlus sign icon
As of December 2025, Todos Medical has approximately 11 employees across 2 continents, including North AmericaAsia. Key team members include Cto: U. Z.Vice President Clinical Laboratory Services & Business Development: A. B.Marketing Manager: S. J.. Explore Todos Medical's employee directory with LeadIQ.

What industry does Todos Medical belong to?

Minus sign iconPlus sign icon
Todos Medical operates in the Biotechnology Research industry.

What technology does Todos Medical use?

Minus sign iconPlus sign icon
Todos Medical's tech stack includes WordPressOpen GraphoEmbedGoogle WorkspacejQuery MigratePHPYoast SEOGoDaddy.

What is Todos Medical's email format?

Minus sign iconPlus sign icon
Todos Medical's email format typically follows the pattern of First.L@todosmedical.com. Find more Todos Medical email formats with LeadIQ.

How much funding has Todos Medical raised to date?

Minus sign iconPlus sign icon
As of December 2025, Todos Medical has raised $3.4M in funding. The last funding round occurred on Jan 25, 2021 for $3.4M.

When was Todos Medical founded?

Minus sign iconPlus sign icon
Todos Medical was founded in 2010.

Todos Medical

Biotechnology ResearchNew York, United States11-50 Employees

Founded in Rehovot, Israel with offices in New York City, Todos Medical Ltd. (OTCQB: TOMDF) engineers life-saving diagnostic solutions for the early detection of a variety of cancers. The Company's state-of-the-art and patented Todos Biochemical Infrared Analyses (TBIA) is a proprietary cancer-screening technology using peripheral blood analysis that deploys deep examination into cancer's influence on the immune system, looking for biochemical changes in blood mononuclear cells and plasma. Todos' two internally-developed cancer-screening tests, TMB-1 and TMB-2, have received a CE mark in Europe. Todos recently acquired U.S.-based medical diagnostics company Provista Diagnostics, Inc. to gain rights to its Alpharetta, Georgia-based CLIA/CAP certified lab currently performing PCR COVID testing and Provista's proprietary commercial-stage Videssa® breast cancer blood test.

Todos is also developing blood tests for the early detection of neurodegenerative disorders, such as Alzheimer's disease. The Lymphocyte Proliferation Test (LymPro Test™) is a diagnostic blood test that determines the ability of peripheral blood lymphocytes (PBLs) and monocytes to withstand an exogenous mitogenic stimulation that induces them to enter the cell cycle. It is believed that certain diseases, most notably Alzheimer's disease, are the result of compromised cellular machinery that leads to aberrant cell cycle re-entry by neurons, which then leads to apoptosis. LymPro is unique in the use of peripheral blood lymphocytes as a surrogate for neuronal cell function, suggesting a common relationship between PBLs and neurons in the brain.

Todos has entered into distribution agreements with companies to distribute certain novel coronavirus (COVID-19) test kits. The agreements cover multiple international suppliers of PCR testing kits and related materials and supplies, as well as antibody testing kits from multiple manufacturers after completing validation of said testing kits and supplies.

Section iconCompany Overview

Headquarters
40 Wall Street, Suite 2702
Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2010
Employees
11-50

Section iconFunding & Financials

  • $3.4M

    Todos Medical has raised a total of $3.4M of funding over 3 rounds. Their latest funding round was raised on Jan 25, 2021 in the amount of $3.4M.

  • $1M

    Todos Medical's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $3.4M

    Todos Medical has raised a total of $3.4M of funding over 3 rounds. Their latest funding round was raised on Jan 25, 2021 in the amount of $3.4M.

  • $1M

    Todos Medical's revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.